توثيق جمعية علم النفس الأمريكية APA (الطبعة السابعة)

Eaton, C., Wells, J., Holen, I., Croucher, P., & Hamdy, F. (2004). Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.

توثيق أسلوب شيكاغو (الطبعة السابعة عشر)

Eaton, C., J. Wells, I. Holen, P. Croucher, و F. Hamdy. Serum Osteoprotegerin (OPG) Levels Are Associated with Disease Progression and Response to Androgen Ablation in Patients with Prostate Cancer. 2004.

توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)

Eaton, C., et al. Serum Osteoprotegerin (OPG) Levels Are Associated with Disease Progression and Response to Androgen Ablation in Patients with Prostate Cancer. 2004.